Eight outstanding postdoctoral researchers were awarded the 2024 BIO5 Postdoctoral Fellowship, which aims to propel interdisciplinary researchers to the next stage of their careers.

Sparked by $150 million in state funding, the Center for Advanced Molecular and Immunological Therapies will support research to catalyze the next generation of precision health care treatments.

Gov. Doug Ducey announced $150 million in funding for the Center for Advanced Molecular and Immunological Therapies, a center being developed by the University of Arizona Health Sciences.

UArizona researchers studied the evolution of the immune system to find a new way to activate T cells to fight infection and disease.

UArizona researchers discuss the processes of basic science which leads to breakthrough discoveries in health and wellness.

Despite slowdowns in research suffered by universities around the world due to the pandemic, the University of Arizona has experienced solid growth in the commercialization of university inventions.

A new study has found that a novel T cell genetically engineered by University of Arizona Health Sciences researchers is able to target and attack pathogenic T cells that cause Type 1 diabetes, which could lead to new immunotherapy treatments.

UArizona Health Sciences researchers have created a five-module chimeric antigen receptor T cell that is showing early potential to fight Type 1 diabetes.

A look at Dr. Michael Kuhns' journey through academia and his current research

By looking at an aging mouse's response to West Nile virus, BIO5 member Dr. Michael Kuhns and his research team have discovered that their immune system's T-Cells work differently, not simply decline, as they age. Understanding this, Dr. Kuhns hopes rese